Best Grants for HIV / AIDS in Virgin Islands

Research institutions and multidisciplinary scientific teams in the Virgin Islands and other eligible U.S. territories can apply for National Institutes of Health support to establish Centers for Structural Biology of HIV and other infectious diseases. Funding supports high-resolution structural analyses, computational modeling, and structure-guided design of molecules to develop new diagnostics and treatments for priority infections.

Grants from the National Institutes of Health help Virgin Islands organizations conduct pilot and feasibility studies on substance use and HIV prevention, treatment, and services research. Eligible projects can develop or adapt interventions, test acceptability and feasibility, or create measures and methods, with required engagement of end users such as policymakers, practitioners, and community members.

Virgin Islands HIV/AIDS research organizations can access funding through the National Institutes of Health to study how HIV immunotherapies affect central nervous system outcomes in people with HIV. This R21/R33 opportunity supports biphasic projects evaluating mechanisms, benefits, and risks in the CNS, with awards up to US $2,000,000 for qualified investigators and teams.

Research institutions and clinical organizations conducting HIV and HIV-associated disease clinical trials can access funding through the National Institutes of Health in the Virgin Islands and other eligible locations. Grants support Clinical Trials Units that run randomized prevention and treatment studies, implementation research, and maintain clinical research sites with the capacity to recruit and retain relevant participants.

Research institutions with capacity to run HIV clinical trials and advanced data systems in the Virgin Islands can access funding through the National Institutes of Health to serve as Statistical and Data Management Centers. Awards support leadership in trial design, data collection and integration, monitoring, analysis, and regulatory-compliant data management for HIV and related studies.

Research institutions and clinical laboratories in the Virgin Islands working on HIV/AIDS prevention and treatment can apply for National Institutes of Health support to serve as Clinical Trials Network Laboratory Centers. Funding supports laboratory infrastructure, regulatory-standard testing, data systems, and advanced assays for HIV clinical trials and implementation research, including work with U.S. territories.

Research institutions and clinical trial networks focusing on HIV/AIDS prevention, treatment, and implementation science can access funding via the National Institutes of Health to lead Clinical Trials Network Leadership and Operations Centers. Centers will guide agendas on therapeutics, biomedical and immune-based prevention, and care for adults, adolescents, maternal, and pediatric populations, including work benefiting the Virgin Islands.

Research institutions and laboratories in the Virgin Islands conducting HIV/AIDS research can apply for US $212,004 - US $2,725,311 to develop and manage specific pathogen free (SPF) models and human new approach methodologies. The US Dept. of Health & Human Services: National Institutes of Health supports NAMs-enabled stewardship frameworks and high-quality SPF colony resources to advance rigorous, translational HIV studies.

Research institutions conducting interdisciplinary HIV/AIDS mental health research in the Virgin Islands can access funding through the National Institutes of Health. Grants from NIH help HIV/AIDS programs develop and sustain AIDS Research Centers that advance basic, clinical, behavioral, social, and implementation science, foster collaboration, and disseminate findings to agencies, communities, and other stakeholders.

Health and public health agencies working on HIV/AIDS care and prevention in the Virgin Islands can access funding via the Health Resources & Services Administration to strengthen integrated planning. Focused on HIV/AIDS, this cooperative agreement offers up to US $700,000 for tools, training, and technical assistance to improve coordinated HIV care systems, including RWHAP Parts A and B recipients.

State and territorial health agencies in the Virgin Islands and other U.S. jurisdictions can apply for HIV/AIDS treatment funding to prevent, reduce, or eliminate AIDS Drug Assistance Program (ADAP) waiting lists and shortfalls. The Health Resources & Services Administration offers up to US $10,000,000 in Emergency Relief Funds to stabilize and expand ADAP services.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

This project aims to enhance health outcomes for women living with HIV in the South by integrating HIV care with comprehensive women's health services through coordinated Clinic and Community Collaboratives. By funding organizations to implement targeted strategies such as culturally responsive services and learning collaboratives, the initiative seeks to improve access to essential health services, increase the number of women initiating rapid ART, and foster sustainable healthcare models that address the unique needs of this population.

The Ryan White HIV/AIDS Program Part D provides supplemental funding aimed at enhancing the infrastructure and capacity of organizations to deliver high-quality, family-centered HIV care services. This initiative focuses on two key areas: HIV Care Innovation and Infrastructure Development, ensuring improved access to essential services for women, infants, children, and youth affected by HIV.

The Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance aims to enhance the capacity of ADAPs. By providing essential tools and expert guidance, the program seeks to improve health outcomes for individuals living with HIV in an evolving healthcare landscape. This initiative is funded by the US HHS through the Health Resources & Services Administration, ensuring support and resources are effectively allocated to meet the needs of vulnerable populations.

The SCORCH Program: Phase 2 aims to enhance the understanding of single cell biology in the context of HIV and Substance Use Disorder (SUD). Building on previous research, this initiative will explore new single cell approaches to investigate the interactions between SUD and HIV progression at various biological levels. By leveraging advanced techniques, the program seeks to identify candidate mechanisms and potential therapeutic targets, ultimately contributing to innovative solutions for SUDs and HIV-related challenges.

The LAST MILE program, initiated by the NIAID, aims to enhance the implementation and effectiveness of HIV prevention and treatment strategies through real-world effectiveness trials. By fostering collaborations and focusing on diverse populations, this initiative seeks to translate clinical findings into practical applications. The program supports research across various disciplines, aligning with the NIH's mission to improve HIV/AIDS outcomes and address associated comorbidities. This multifaceted approach promises to bridge the gap between clinical trials and community-based interventions.

Research institutions and clinical trial networks focused on HIV treatment and prevention for infants, children, adolescents, young adults, and maternal populations in the Virgin Islands and other U.S. territories can pursue this upcoming opportunity, with awards up to US $30,000,000. With a mission to advance child and maternal health, National Institutes of Health will fund collaborative HIV clinical trials and related comorbidity studies.

Researchers and investigators conducting innovative HIV and substance use or substance use disorder studies in the Virgin Islands can seek high-risk, high-reward funding through the National Institutes of Health. US Dept. of Health & Human Services: National Institutes of Health supports pioneering biomedical and behavioral HIV research, including early stage investigators, with awards ranging from US $350,000 - US $700,000.

Research institutions and similar organizations studying HIV-related biological, behavioral, or social mechanisms affecting NIDDK-relevant organs can seek up to US $275,000 for pilot projects in the Virgin Islands and other U.S. locations. US Dept. of Health & Human Services: National Institutes of Health supports work on HIV comorbidities, coinfections, complications, and viral reservoirs.

The NIDCD is offering funding to advance HIV/AIDS research, particularly focusing on areas related to communication disorders. This initiative supports low-risk clinical trials and encourages researchers to align their proposals with high priority topics identified by the NIH Office of AIDS Research. Applications must be submitted by the local deadline, with optional Letters of Intent due 30 days prior to the proposal deadline. This opportunity aims to enhance understanding and treatment in this crucial health area.

The Academic Research Enhancement Award (AREA) supports small-scale research grants for institutions with limited NIH funding, emphasizing biomedical research experiences for undergraduates. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over the past seven years. This initiative aims to enhance the research environment at these institutions, fostering student involvement in research activities.

The High Priority HIV and Substance Use Research funding opportunity aims to support innovative research that addresses the intersection of HIV and substance use. Researchers are encouraged to submit proposals that include a detailed research plan and preliminary data, exploring new avenues for prevention, treatment, and potential cures for HIV among people who use drugs. Applications are due by 5 PM local time, with optional Letters of Intent recommended 30 days prior.